176 related articles for article (PubMed ID: 23611920)
21. Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease.
Eker S; Ayaz L; Tamer L; Ulubas B
Scand J Clin Lab Invest; 2010 Feb; 70(1):40-4. PubMed ID: 20021311
[TBL] [Abstract][Full Text] [Related]
22. Association of plasma netrin-1 level with inflammatory balance and comorbidities in patients with acute exacerbation of COPD.
Kerget B; Afşin DE; Kerget F; Koçak AO; Aksakal A; Kızıltunç A; Araz Ö; Yılmazel Uçar E; Akgün M
Tuberk Toraks; 2021 Mar; 69(1):30-38. PubMed ID: 33853303
[TBL] [Abstract][Full Text] [Related]
23. Proteoglycan 4 is a diagnostic biomarker for COPD.
Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC
Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097
[TBL] [Abstract][Full Text] [Related]
24. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
[TBL] [Abstract][Full Text] [Related]
25. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.
Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E
Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328
[TBL] [Abstract][Full Text] [Related]
26. IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients.
Savchenko L; Mykytiuk M; Cinato M; Tronchere H; Kunduzova O; Kaidashev I
Int J Chron Obstruct Pulmon Dis; 2018; 13():2569-2575. PubMed ID: 30197513
[TBL] [Abstract][Full Text] [Related]
27. Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease.
Kythreotis P; Kokkini A; Avgeropoulou S; Hadjioannou A; Anastasakou E; Rasidakis A; Bakakos P
BMC Pulm Med; 2009 Apr; 9():11. PubMed ID: 19344528
[TBL] [Abstract][Full Text] [Related]
28. Leptin, resistin and fetuin a concentration as the potential useful biomarkers in stable COPD - An exploratory study.
Małujło-Balcerska E; Kumor-Kisielewska A; Śmigielski W
Cytokine; 2023 Sep; 169():156275. PubMed ID: 37354646
[TBL] [Abstract][Full Text] [Related]
29. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
30. Airway bacterial colonization and serum C-reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction.
Fruchter O; Rosengarten D; Goldberg E; Ben-Zvi H; Tor R; Kramer MR
Clin Respir J; 2016 Mar; 10(2):239-45. PubMed ID: 25196428
[TBL] [Abstract][Full Text] [Related]
31. [Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease].
Peng M; Cai BQ; Ma Y; Zhu HJ; Sun Q; Song AL
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):182-5. PubMed ID: 17572996
[TBL] [Abstract][Full Text] [Related]
32. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
33. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy.
Pina T; Genre F; Lopez-Mejias R; Armesto S; Ubilla B; Mijares V; Dierssen-Sotos T; Gonzalez-Lopez MA; Gonzalez-Vela MC; Blanco R; Hernández JL; Llorca J; Gonzalez-Gay MA
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1995-2001. PubMed ID: 25823684
[TBL] [Abstract][Full Text] [Related]
34. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
[TBL] [Abstract][Full Text] [Related]
35. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
36. [Serum myostatin levels and malnutrition in patients with chronic obstructive pulmonary disease].
Ju CR; Chen RC
Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):465-8. PubMed ID: 21781527
[TBL] [Abstract][Full Text] [Related]
37. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
38. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
40. Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation.
Wu YQ; Shen YC; Wang H; Zhang JL; Li DD; Zhang X; Wang T; Xu D; Ying BW; Wang LL; Wen FQ
Eur Rev Med Pharmacol Sci; 2016; 20(1):44-53. PubMed ID: 26813452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
